Giuseppe Caruso: ESMO Gynae 2026 Advancing ADCs in Ovarian Cancer
Giuseppe Caruso, Medical Consultant at IEO Istituto Europeo di Oncologia, shared a post on LinkedIn:
“One month to go until ESMO Gynae 2026 in Copenaghen. Excited to join as discussant on MIRV and the evolving role of ADCs in the platinum-eligible ovarian cancer setting.
What is happening in our field is truly a tsunami
We are playing a new board game with ADCs – ‘ADC-opoly’ – and reshaping treatment algorithms.
ESMO – European Society for Medical Oncology – OncoDaily – OncoAlert”
Fabian Trillsch, Deputy Director at LMU University Hospital Munich, shared Giuseppe Caruso’s post, adding:
“Indeed, Giuseppe Caruso this will be a great opportunity to put the upcoming data on ADCs for ovarian cancer in context.
Really looking forward to presenting the latest results of the AGO-OVAR 2.34/ MIROVA trial at ESMO Gynae 2026 and to discussing it with you and the audience!!
Great session, see you in Copenhagen!! 🤗 🇩🇰
ESMO – European Society for Medical Oncology
AGO Studiengruppe
ovarian cancer
ADC”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 10, 2026, 04:36Tess Kossow: Why I Created Nurture IVF Concierge After My Own Infertility Journey
-
Oct 10, 2026, 04:32Hosting the First Advanced Obstetric Surgical Skills Course – RCOG
-
Oct 10, 2026, 04:29Beyond IVF Laboratory Optimization: Addressing Patient Dropout – RBMO
-
Oct 10, 2026, 04:22Does Lifestyle Really Affect Fertility? – Montgomery Fertility Center
-
Oct 10, 2026, 04:20Mamoon Banat: Quick Recap of the 2026 CFAS Meeting in Calgary, Canada
-
Oct 8, 2026, 17:18Khalil Faaed: Vitrification Prevents Ice, but Does It Prevent Oocyte Damage?
-
Oct 8, 2026, 17:16Ritu Anand: Better Conversations Ultimately Lead to Better Care in Fertility
-
Oct 8, 2026, 17:14Mark Trolice: Excited to Speak at Women’s HealthX
-
Oct 8, 2026, 17:12Delighted to Welcome Dr. RóisÃn Mortimer – Waterstone Clinic-IVF and Fertility